DNM1L and Alzheimer disease: Previously, we mentioned that the formation of SNO-Drp1 in AD increases the GTPase activity of Drp1 and leads to mitochondrial fragmentation, which impairs bioenergetics and induces synaptic damage and neuronal loss.